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1Humans, high-order primates, and rodents display hemo-chorial placentation characterized by direct contact of 
maternal blood with fetal chorionic trophoblast cells to opti-
mize fetal–maternal interactions.1–3 Hemochorial placentation 
requires trophoblast cell invasion into uterine tissue, which is 
associated with remodeling of uterine spiral arteries.4 Both 
trophoblast cell invasion and spiral artery remodeling are key 
steps to allow optimal gas exchange and nutrient supply to 
the developing fetus. In the human, failure of these processes 
may result in intrauterine growth restriction and preeclamp-
sia.5 Preeclampsia is a multisystemic pregnancy disorder, 
featuring new-onset maternal hypertension and proteinuria 
after 20 weeks of gestation.6 In many cases, preeclampsia is 
associated with a growth-restricted fetus.7 Preeclampsia is also 
associated with long-term, increased, cardiovascular risk for 
both mother8 and child.9 Recently, circulating antiangiogenic 
factors10 and unappreciated maternal immune recognition of 
the fetus11 have shed mechanistic light on preeclampsia. The 
invasion of the semiallogenic zygote-derived trophoblast cells 
into the maternal uterus requires a tolerant maternal immune 
milieu. Failed tolerance could explain the typical, shallow, tro-
phoblast cell invasion in preeclampsia. Uterine natural killer 
Abstract—Uterine natural killer cells are important for uteroplacental development and pregnancy maintenance. Their role 
in pregnancy disorders, such as preeclampsia, is unknown. We reduced the number of natural killer cells by administering 
rabbit anti-asialo GM1 antiserum in an established rat preeclamptic model (female human angiotensinogen×male human 
renin) and evaluated the effects at the end of pregnancy (day 21), compared with preeclamptic control rats receiving 
normal rabbit serum. In 100% of the antiserum-treated, preeclamptic rats (7/7), we observed highly degenerated vessel 
cross sections in the mesometrial triangle at the end of pregnancy. This maternal uterine vasculopathy was characterized 
by a total absence of nucleated/living cells in the vessel wall and perivascularly and prominent presence of fibrosis. 
Furthermore, there were no endovascular trophoblast cells within the vessel lumen. In the control, normal rabbit 
serum–treated, preeclamptic rats, only 20% (1/5) of the animals displayed such vasculopathy. We confirmed the results 
in healthy pregnant wild-type rats: after anti-asialo GM1 treatment, 67% of maternal rats displayed vasculopathy at 
the end of pregnancy compared with 0% in rabbit serum–treated control rats. This vasculopathy was associated with 
a significantly lower fetal weight in wild-type rats and deterioration of fetal brain/liver weight ratio in preeclamptic 
rats. Anti-asialo GM1 application had no influence on maternal hypertension and albuminuria during pregnancy. 
Our results show a new role of natural killer cells during hypertensive pregnancy in maintaining vascular integrity. 
In normotensive pregnancy, this integrity seems important for fetal growth.  (Hypertension. 2016;68:00-00. 
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(uNK) cells make up the majority of leucocytes in the uterine 
implantation site.12 Although uNK cells contain perforin and 
granzyme-filled cytoplasmic granules, they exhibit less cyto-
toxic activity against major histocompatibility complex class-
I–negative target cells, compared with circulating natural killer 
(NK) cells.13 Furthermore, uNK cells do not exhibit NK activ-
ity against trophoblast cells.14 In the decidua of preeclamptic 
patients, changes in uNK cells and T-lymphocyte subsets could 
affect local immunoregulatory mechanisms.15
Chakraborty et al16 showed that in rats, uNK cells are 
involved in hemochorial placentation by regulating tro-
phoblast cell lineage decisions. Moreover, they presented 
results showing that endovascular trophoblast cell invasion is 
increased in wild-type rats during midpregnancy after deple-
tion of uNK cells. However, they did not examine effects on 
late and pathological pregnancies. Because shallow endo-
vascular trophoblast cell invasion is considered to be causal 
for the pathological event initiating preeclampsia symptoms 
and signs,17 we hypothesized that depletion or reduction of 
NK cells associated with increased trophoblast cell invasion 
ameliorates the preeclamptic phenotype in our rat model. We 
worked with our double-transgenic rat preeclamptic model 
where the preeclamptic phenotype has been established in 
rats18 and mice.19 The dams expressing human angiotensino-
gen develop hypertension and proteinuria during pregnancy 
after mating with males expressing the human renin.18 The off-
spring are growth restricted,20 comparable to what is observed 
in spontaneously occurring, early-onset preeclampsia in preg-
nant women. The model exhibits pathological endovascular 
trophoblast cell invasion with altered uteroplacental vascular 
remodeling.21,22
Methods
Local government authorities approved the studies along guidelines 
provided by the American Physiological Society. Detailed description 
of methods is available in the online-only Data Supplement.
Analysis of Maternal Uterine Vasculopathy
One uteroplacental unit per mother rat was investigated for analysis 
of maternal vasculopathy (n=7 anti-asialo GM1-treated, preeclamptic 
rats versus n=5 normal rabbit serum–treated, control, preeclamptic 
rats, and n=6 anti-asialo GM1-treated, wild-type, Sprague-Dawley 
[SD] rats versus n=5 normal rabbit serum–treated, SD control rats). 
In preeclamptic rats, at least 4 series of sections from the center of 
the uteroplacental unit were examined per rat. Each series consisted 
of 10 consecutive sections, 3 µm thick. The distance between the 
series was 100 µm. In SD rats, at least 15 series of sections from the 
uteroplacental unit were examined (also covering the central parts). 
Each series consisted of at least 5 consecutive sections, 3 µm thick. 
The distance within the series was 100 µm. Terminal deoxynucleo-
tidyl transferase dUTP nick end labeling assay was performed with 
the TMR In Situ Cell Death Detection Kit (Roche) as recommended 
by the manufacturer. To visualize cell nuclei, slides were counter-
stained with the DNA dye Hoechst 33342 (Sigma) and mounted 
using Vectashield antifade mounting medium (Vector Laboratories). 
Sections were investigated and imaged by Zeiss Axio Imager M2 
fluorescence upright microscope (Zeiss) using either ×10 or ×40 
Plan–Apochromat objectives (Zeiss). Pictures were taken with the 
AxioCam HRc camera (Zeiss).
Statistics
All statistics were done with GraphPad Prism 6. The blood pres-
sure data were analyzed by repeated-measures 2-way ANOVA and 
Bonferroni multiple comparisons test. With all other data, Grubb 
test was performed, outliners were excluded (exception: resorption 
data), and normal distribution calculated by Kolmogorov–Smirnov 
test or D’Agostino–Pearson omnibus normality test. For group differ-
ences, either the unpaired t test (for normally distributed data) or the 
Mann–Whitney test (for not normally distributed data) was applied. 
In case of different variances within normally distributed data, an 
unpaired t test with Welch correction was performed. The quantita-
tive, real-time, reverse transcription polymerase chain reaction results 
on mesometrial triangle with regard to uNK cells were evaluated with 
the nonparametric 1-way ANOVA, Kruskal–Wallis test, and Dunn 
multiple comparisons test. Values are shown as mean±SEM (nor-
mally distributed data) or median with interquartile range (not nor-
mally distributed data). P values <0.05 were considered significant 
(*), P<0.01 (**), P<0.001 (***), and P<0.0001 (****).
Results
Reduction of Uterine Natural Killer Cells in 
Preeclamptic Rats on Pregnancy Day 15 After Anti-
Asialo GM1 Application
We first investigated whether NK cell reduction on pregnancy 
day 15 was successful after anti-asialo GM1 therapy in pre-
eclamptic rats. In control, rabbit serum–treated, preeclamptic 
dams on day 15 of pregnancy, 2.5±0.1% of the splenic lym-
phocytes were NK cells (CD161 positive and CD3 negative), 
whereas only 0.5±0.0% of the splenic lymphocytes were NK 
cells after anti-asialo GM1 treatment, which means that the 
NK cell population was reduced by 80% (Figure 1A). In the 
mesometrial triangle of the uteroplacental unit of preeclamp-
tic rats, NK cells were also decreased after anti-asialo GM1 
therapy (Figure 1B through 1D). Immunohistochemical 
analysis on day 15 of pregnancy demonstrated that uNK cells 
were present around vessels in control, rabbit serum–treated, 
preeclamptic rats (Figure 1B, left) but were significantly 
reduced after anti-asialo GM1 administration (Figure 1B, 
right). Quantification revealed that anti-asialo GM1 treatment 
reduced the number of uNK cells in the mesometrial triangle 
of preeclamptic rats by 60% (Figure 1C). This finding was 
confirmed by quantitative, real-time, reverse transcription 
polymerase chain reaction (Figure 1D) in the uteroplacental 
unit of preeclamptic rats on pregnancy day 15, showing that 
the mRNA expression of the NK cell marker NKp46 (natural 
cytotoxicity receptor 1), expressed by all rat conventional NK 
cells, was decreased by 89%. As expected, uNK cells were 
hardly present in the uteroplacental unit of preeclamptic rats 
at the end of pregnancy (day 21), irrespective of anti-asialo 
GM1 treatment.
Maternal Vasculopathy in the Uterus of 
Preeclamptic Rats on Pregnancy Day 21 After Anti-
Asialo GM1 Application
After anti-asialo GM1 application, we found degenerative 
spiral artery cross sections surrounded by cell detritus and 
fibrosis in the mesometrial triangle of preeclamptic rats, the 
maternal part of the uteroplacental unit (Figure 2A through 2E; 
Figure S1A through S1E in the online-only Data Supplement). 
We observed in every anti-asialo GM1-treated, preeclamptic 
mother rat (7/7, 100%) at least one of such pathological cross 
section at the end of pregnancy (Figure 
Golic et al  NK Cells and Uteroplacental Vasculopathy  3
characterized by the absence of cell nuclear staining in peri-
vascular cells and in the vascular smooth muscle cells of 
the vessel wall (Figure 3B). Vascular smooth muscle cells 
were not detectable in these cross sections (Figure 2C), and 
endovascular trophoblast cells were almost totally absent 
(Figure 2D). Moreover, there was increased presence of apop-
totic cells within the vasculopathy (Figure 3B).
Trophoblast Cell Invasion in Preeclamptic Rats 
on Pregnancy Day 21 After Anti-asialo GM1 
Application
After anti-asialo GM1 application, interstitial trophoblast cell 
invasion (Figure S2A) into the mesometrial triangle of pre-
eclamptic rats was diminished at the end of pregnancy (ges-
tational day 21). In parallel, the number of trophoblast cells 
in the successfully invaded mesometrial triangle was signifi-
cantly decreased after anti-asialo GM1 (Figure S2B).
Endovascular trophoblast cell invasion into the mesome-
trial triangle of preeclamptic rats (Figure S3A through S3C) 
was unchanged after anti-asialo GM1 treatment. This finding 
corresponded to the unchanged amount of vascular smooth 
muscle α-actin in trophoblast cell–invaded arteries (Figure 
S3D and S3E), indicating an unchanged spiral artery remodel-
ing. The number of spiral artery cross sections in the meso-
metrial triangle of preeclamptic rats was not different after 
anti-asialo GM1 treatment (data not shown).
Angiogenic Factors and Interleukin 15 in 
Uteroplacental Unit of Preeclamptic Rats on 
Pregnancy Day 21 After Anti-Asialo GM1 
Application
We further investigated the uteroplacental units of preeclamp-
tic rats on pregnancy day 21. In the placenta, the fetal part of 
the uteroplacental unit, anti-asialo GM1 application decreased 
soluble, fms-like tyrosine kinase 1 (sFLT-1; Figure S4A) and 
placental growth factor (PlGF; Figure S4B) protein concentra-
tion, leading to an unchanged sFLT-1/PlGF ratio in preeclamp-
tic rats (Figure S4C). Gene expression of sFLT-1 and PlGF in 
placenta was not different between the 2 preeclamptic groups 
(data not shown). In mesometrial triangle of preeclamptic rats, 
the maternal part of the uteroplacental unit, there was neither 
Figure 1. Reduction of natural killer cells on pregnancy day 15 in 
preeclamptic (PE) rats. A, Anti-asialo GM1 reduced natural killer 
cells (NK cells) in the maternal spleen of PE rats on pregnancy day 
15 by 80% (n=3 per group). Two-color, flow cytometry contour 
plots displaying CD161 fluroesceinisothiocyanate (FITC) vs CD3 
allophycocyanin (APC), or isotype control. B, Histological section 
images from the mesometrial triangle on day 15 of pregnancy of 
a control, rabbit serum–treated and an anti-asialo GM1-treated 
PE rat, respectively, ×20 magnification. Immunohistochemical 
staining with anti-natural killer cell activation structures (ANK61) 
to detect uterine natural killer cells (uNK cells), which appear in 
black after nitro-blue tetrazolium chloride and 5-bromo-4-chloro-
3′-indolylphosphate p-toluidine salt staining and counterstaining 
with periodic acid–Schiff and hematoxylin. Anti-asialo GM1 
reduced uNK cells in the mesometrial triangle of PE rats on 
pregnancy day 15. C, Quantification of the ANK61-positive 
staining of mesometrial triangles of PE rats on pregnancy day 
15. Positive cells were evaluated semiquantitatively by counting 
them in 3 complete microscopic fields per mesometrial triangle 
(n=3 mesometrial triangles from anti-asialo GM1-treated PE rats 
and n=3 mesometrial triangles from control rabbit serum–treated 
PE rats, all mesometrial triangles from different mother rats). Anti-
asialo GM1 reduced the mean number of ANK-positive cells in 
the mesometrial triangle by 60% (60±8 cells per microscopic field 
in ×40 magnification vs 150±15 cells in the PE, control, rabbit 
serum–treated group; P<0.0001, unpaired t test, (Continued )  
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a difference in protein concentration of sFLT-1 (Figure S4A) 
and PlGF (Figure S4B), nor in the ratio of both (Figure S4C). 
Gene expression displayed similar results (data not shown). 
The sFLT-1/PLGF ratio in maternal preeclamptic plasma at 
the end of pregnancy was also unchanged (Figure S4D). Anti-
asialo GM1 decreased gene expression of interleukin 15 in the 
preeclamptic placenta by 14% (Figure S4E) and increased it 
in the mesometrial triangle by 47%.
Influence of Anti-Asialo GM1 Application on Fetal 
Outcome and Maternal Phenotype in Preeclamptic 
Rats on Pregnancy Day 21
We then analyzed the influence of anti-asialo GM1 treatment 
on fetuses of preeclamptic rats, concentrating on intrauterine 
growth retardation on pregnancy day 21. Anti-asialo GM1 
application increased fetal brain/liver weight ratio in pre-
eclamptic rats (Figure 4A). Fetal liver weight (Figure S5A) 
was decreased, whereas fetal brain weight (Figure S5B) and 
total fetal weight (Figure 4B) in preeclamptic rats remained 
unchanged. There was neither a difference in the number 
of fetuses (Figure S5C), nor in the number of resorptions 
per mother rat (Figure S5D) between the 2 preeclamptic 
groups. In preeclamptic mother rats, NK cell reduction did 
not influence the preeclampsia-defining signs, hypertension 
(Figure 4C) and albuminuria (Figure S5E). Systolic and dia-
stolic blood pressure measured by telemetry showed no dif-
ference between both preeclamptic groups (data not shown). 
Additionally, serum creatinine (Figure S5F), serum cystatin C 
(Figure S5G), and maternal body weight (Figure S5H) were 
not changed in preeclamptic rats after anti-asialo GM1 appli-
cation. The uteroplacental units (Figure 4D) were heavier, 
and the uteroplacental unit/fetal weight ratio (Figure 4E) 
was increased in preeclamptic rats after anti-asialo GM1 
application.
Influence of Anti-asialo GM1 Application in Wild-
Type Rats on Pregnancy Day 21
We finally investigated the influence of anti-asialo GM1 appli-
cation on healthy, wild-type, SD rats on pregnancy day 21. 
Anti-asialo GM1 or rabbit serum, respectively, was applied 
according to the same protocol used in our preeclamptic rats. 
We found uterine maternal vasculopathy in 66.7% (4/6) of 
anti-asialo GM1-treated, SD mother rats (Figure 5A). None of 
the rabbit serum–treated, control SD mothers displayed uter-
ine vasculopathy. One anti-asialo GM1-treated, SD mother rat 
carried 11 implantation sites with 10 resorptions and 1 highly 
growth-restricted fetus (1.6 g). In the center of this specimen’s 
mesometrial triangle (Figure 5B), there was a large area com-
pletely lacking nuclear staining. Within this area, we discov-
ered several vessel cross sections displaying vasculopathy and 
increased terminal deoxynucleotidyl transferase dUTP nick 
end labeling positivity. In SD rats, anti-asialo GM1 decreased 
fetal weight significantly (3.7 versus 3.9 g in the control rabbit 
Figure 2. Influence of anti-asialo GM1 on maternal uterine 
vessels in preeclamptic (PE) rats on pregnancy day 21. 
Photomicrographs of degenerative maternal vasculopathy in the 
mesometrial triangle of PE rats. In every anti-asialo GM1-treated, 
PE rat (n=7), we found at least one degenerative vessel cross 
section with massive fibrosis. In control, rabbit serum–treated 
PE rats (n=5), just one mother rat displayed vasculopathy. 
Shown are representative parallel stainings of an anti-asialo 
GM1-treated, PE rat and a control, rabbit serum–treated PE 
rat. A, Masson–Goldner trichrome staining, which typically 
stains collagen green. Around the vessels in the anti-asialo 
GM1-treated, PE rat, there is a huge perivascular collagen 
accumulation/fibrosis, which is not present in the control, 
rabbit serum–treated PE mesometrial triangle. The lumen of 
the spiral artery in the anti-asialo GM1-treated, PE rat seems 
almost totally filled with cells and exudate with just a minority 
being erythrocytes (red in Masson–Goldner trichrome staining). 
B, Periodic acid–Schiff (PAS) staining and counterstaining with 
hematoxylin. In the anti-asialo GM1-treated, PE rat, there are a 
lot of rounded cells, which have lost their connectivity. These 
cells show no nuclear staining with hematoxylin, indicating an 
advanced cell damage. C, Diaminobenzidine staining of α-actin 
and counterstaining with PAS and hematoxylin, after which 
smooth muscle cells usually appear in brown. In the wall of 
degenerative vessels (in the anti-asialo GM1-treated, PE rat), 
there was no α-actin of smooth muscle cells detectable anymore. 
D, Cytokeratin staining of trophoblast cells, which appear in 
black after nitro-blue tetrazolium chloride (NBT) and 5-bromo-4-
chloro-3′-indolylphosphate p-toluidine salt (BCIP) staining and 
counterstaining with PAS and hematoxylin. The degenerative 
vessel cross sections in the anti-asialo GM1-treated PE rat are 
hardly infiltrated by endovascular trophoblast cells, whereas there 
are a lot of interstitial trophoblast cells present. E, CD31 staining 
of endothelial cells (NBT and BCIP staining and (Continued )  
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serum SD group; Figure 5C). Fetal brain/liver weight ratio 
(Figure 5D; Figure S6A and S6B), weight of uteroplacen-
tal unit (Figure 5E), and the uteroplacental unit/fetal weight 
ratio (Figure 5F) were unchanged between both SD groups. 
Moreover, maternal blood pressure, albuminuria, and number 
of fetuses and resorptions were not changed after anti-asialo 
GM1 treatment in SD rats in comparison to rabbit serum–
treated SD rats (data not shown).
Discussion
We successfully reduced NK cell numbers in our preeclamp-
tic rats by administering anti-asialo GM1 antiserum. This 
effect was associated with a pathological phenotype at the 
fetal–maternal interface. Maternal uterine vasculopathy with 
presumably dead cells in the vessel wall and in the perivas-
cular zone occurred in every preeclamptic and in the major-
ity of wild-type SD rats after anti-asialo GM1 application. 
The vasculopathy was associated with a deterioration of fetal 
outcome, which was more pronounced in SD rats where fetal 
weight was reduced. Fetuses of preeclamptic rats displayed 
signs of growth restriction (increased fetal brain/liver weight 
ratio as a marker for fetal centralization) after anti-asialo ther-
apy. Reduction of NK cells by anti-asialo GM1 administration 
diminished the area and the density of interstitial trophoblast 
cell invasion in preeclamptic rats. There was no change in 
blood pressure and albuminuria neither in preeclamptic nor in 
SD rats after anti-asialo GM1 treatment.
A vasculopathy associated with NK cell reduction in 
hypertensive pregnancy has heretofore never been shown. 
These data agree with seminal earlier work showing that absent 
NK cells during normotensive murine pregnancy is associ-
ated with uterine vasculopathy suggestive of arteriosclerosis 
and fetal loss.23 Moreover, others have demonstrated involve-
ment of uNK cells in decidual angiogenesis that supports fetal 
growth during early and mid pregnancy.24 We observed degen-
erated maternal vessels with massive dead tissue and fibrosis 
in the mesometrial triangle of NK-reduced animals. We are 
aware that identifying vascular smooth muscle cell degenera-
tion is difficult and that absent nuclear staining in perivascular 
cells as signs of an expanding degeneration of the surround-
ing tissue is imprecise. We interpret our result a nonspecific 
degenerative process, involving also the perivascular area. 
Isolated round cells with a loss of connectivity were occasion-
ally observed in other mesometrial triangles, either anti-asialo 
GM1-treated or in control rabbit serum–treated rats; however, 
on a much smaller scale.
Our findings could also suggest that NK cells are involved 
in maintenance and protection of the maternal uterine vascu-
lar system, perhaps even with long-term implications. The 
vasculopathy was associated with fetal growth restriction in 
wild-type SD rats, and subtle signs of fetal growth restric-
tion effects were observed in preeclamptic rats, even though 
these fetuses were already extremely growth restricted 
(>20% growth restriction in comparison to healthy wild-type 
SD fetuses). We hypothesize that the vasculopathy arose dur-
ing the last third of pregnancy because we did not observe 
vasculopathy in mesometrial triangles of preeclamptic rats 
on pregnancy day 15 (data not shown). We regard the vascu-
lopathy as representing final exhaustion at the end of preg-
nancy when the stress exerted on the maternal cardiovascular 
system increases significantly. In addition, the degenerated 
vessels with absence of intraluminal cells could explain why 
we could not reproduce the results reported by Chakraborty 
et al.16 They reported increased endovascular trophoblast cell 
invasion on pregnancy day 14 in wild-type rats after anti-
asialo GM1 administration. In our study of preeclamptic rats 
on pregnancy day 21, endovascular trophoblast cell invasion 
was not different from controls. Besides vasculopathy, this 
conflicting result could also be because of the different time 
points of analysis and the fact that Chakraborty et al used 
healthy wild-type rats, whereas we tested NK cell reduction 
in a transgenic preeclamptic model. Chakraborty et al did 
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not mention maternal vasculopathy; however, they did not 
investigate later time points.
The second important finding of our study was the decreased 
interstitial trophoblast cell invasion in preeclamptic rats with 
reduced number of NK cells. In humans and rats, trophoblast 
cells invade the uterine interstitium25,26 and the lumina of spiral 
arteries.27,28 In rats, interstitial trophoblast cell invasion occurs 
after endovascular invasion.25 This finding again supports our 
hypothesis that the observed vasculopathy occurred at the end 
of pregnancy, hampering physiological interstitial tropho-
blast cell invasion and a putative (according to Chakraborty 
et al16) increased endovascular trophoblast cell invasion. The 
increased weight of the uteroplacental unit in anti-asialo 
GM1-treated preeclamptic rats and especially their increased 
uteroplacental unit/fetal weight ratio could reflect placental 
insufficiency as a consequence of decreased trophoblast cell 
invasion. Traditionally, an increased placental/fetal weight 
ratio has been used as a marker for an inefficient placenta.29 An 
alternative way to demonstrate placental insufficiency would 
be to study umbilical Doppler images, which should be consid-
ered in further experiments. The decreased interstitial tropho-
blast cell invasion is in accordance with earlier work showing 
that in humans decidual NK cells, but not peripheral blood-
derived NK cells, support trophoblast cell invasion and induce 
angiogenesis in the decidua.30 These processes are 2 important 
events in early pregnancy. Recently, Kieckbusch et al showed 
that a major histocompatibility complex–mediated inhibition 
of uNK cells leads to slightly diminished fetal growth and 
altered spiral artery remodeling in mice.31 Reduction of NK 
cells did not change spiral artery remodeling in our preeclamp-
tic rats, but we could show a decrease in fetal weight in our 
wild-type SD rats after NK cell reduction. The mouse model is 
problematic because murine intrauterine trophoblast cell inva-
sion is shallow32 compared with humans and rats.
Figure 4. Influence of anti-asialo GM1 on fetal outcome and 
maternal blood pressure in preeclamptic (PE) rats on pregnancy 
day 21. A, Anti-asialo GM1 increased fetal brain/liver weight 
ratio in fetuses of PE mother rats (1.0 vs 0.8 in the control, rabbit 
serum–treated, PE group; P=0.03, Mann–Whitney test, shown 
median with interquartile range); n=72 in the (Continued )  
Figure 4 Continued. anti-asialo GM1 PE group and n=55 in 
the control, rabbit serum–treated, PE group. B, Anti-asialo 
GM1 application did not change fetal weight in PE mother rats 
(2.8 vs 2.9 g in the control, rabbit serum–treated group; P=0.3, 
Mann–Whitney test, shown median with interquartile range); 
n=73 in the anti-asialo GM1-treated, PE group and n=56 in the 
control, rabbit serum–treated PE group. C, Anti-asialo GM1 
treatment of PE rats did not change maternal blood pressure 
during pregnancy. Blood pressure was measured on 16 days 
throughout pregnancy, and there was no difference at any time 
in mean arterial blood pressure between the anti-asialo GM1-
treated, PE and the control, rabbit serum–treated PE group (eg, 
155±3 vs 158±4 mm 
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Natural killer cells are part of the innate immune system 
and characterized by interferon γ production influencing 
immune cells of the adaptive immune system. Interestingly, 
there is increasing evidence that NK cells are related to the 
growing family of innate lymphoid cells (ILCs).33,34 Several 
ILCs express markers such as NKp46 that were formerly con-
sidered to be exclusively expressed on NK cells.34 ILCs are 
non-T and non-B cells mirroring functions of T cells but with 
prompt reaction to antigens or injured tissues.35 Their pres-
ence is locally enriched in barrier surfaces.36 On the basis of 
the signature cytokines they produce,34 there are 3 classes of 
ILCs (ILC1, ILC2, and ILC3) at the moment. Group 1 con-
sists of interferon-γ–producing cells and thus NK cells are 
considered to belong to the ILC1 group. However, NK cells 
can still be distinguished because they display cytotoxicity 
and because their maturation depends on the transcription 
factor eomesodermin.37,38 Furthermore, the transcriptional 
program of NK cells differs, at least in parts, from that of 
ILC1s.33 Thus, they are still commonly referred to as NK 
cells.35 Taken together, the quickly emerging, complex types 
and subtypes of ILCs in addition to their potential for inter-
conversion between ILC groups39 make a clear identification 
of ILC types and their distinction from other immune cells 
almost impossible with current techniques. Thus far, there 
has not been any description of ILCs in the rat, but it is likely 
that they exist there as well. Although we cannot claim that 
we also reduced ILC1s and other ILCs in our study, we can 
conclude on the basis of our results and current knowledge 
that we have reduced what is considered to be NK cells in the 
spleen and uterus at the moment.
Traditionally, NK cells have been considered as a 
homogenous lymphocyte population circulating in blood, 
spleen, and other organs (circulating NK cells). However, 
there is clear evidence that subtypes of NK cells reside in 
tissues (tissue-resident NK cells) such as liver, thymus, 
uterus,40 and the salivary gland41 exhibiting different func-
tions and capabilities. Strikingly, tissue-resident NK cells 
do not seem to require the NK cell specification transcrip-
tion factor Nfil3 (nuclear factor interleukin-3–regulated 
Figure 5. Influence of anti-asialo GM1 on fetal outcome and 
maternal uterine vessels in wild-type, Sprague-Dawley (SD) rats 
on pregnancy day 21. A, Quantification of maternal vasculopathy 
in the mesometrial triangle of SD rats on pregnancy day 21: 
application of anti-asialo GM1 (n=6) induced in 4 of 6 SD mother 
rats (4/6, 66.7%) a vasculopathy (according pictures from Figure 
2). There was no vasculopathy in any rabbit serum–treated, 
SD mother rat (n=5, 0/5, 0%). B, Terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) assay (red) to detect 
apoptotic cells with 4′,6-diamidino-2-phenylindole staining (blue) 
for visualization of cell nuclei. Uteroplacental unit of a highly 
growth-restricted fetus (1.6 g) in a SD mother rat after anti-asialo 
GM1 application. There is a large area of absent nuclear staining 
in the middle of the picture. Within this area, there is TUNEL 
positivity. ×10 magnification. C, Anti-asialo (Continued )  
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protein),41 leading to the assumption that tissue-resident NK 
cells are distinct from circulating NK cells and could repre-
sent a different cell lineage.40 The independence of Nfil3 has 
been shown for uNK cell differentiation in mice as well.42 
Tissue-resident NK cells in the liver develop independent 
of eomesodermin,43 whereas tissue-resident NK cells in the 
uterus highly express eomesodermin,44 suggesting more sim-
ilarities of uNK cells to circulating NK cells. However, the 
precise origin of uNK cells remains unclear. Nevertheless, 
tissue-resident NK cells seem to be distinguishable from 
each other and in parts from ILCs.40 Recently, a population 
of nonkiller uterine ILC3s has been found in human endo-
metrium and decidua.45 Rat uNK cells have not well been 
characterized recently46 and, to our knowledge, rat uterine 
ILCs have never been described.
We used a published, successful protocol to reduce NK 
cells in rats16 by administering anti-asialo GM1 antiserum. This 
antiserum reduces NK cells in almost every organ in the body, 
including spleen16,47 rather than just uNK cells. Moreover, 
anti-asialo GM1 also reacts with nonparenchymal liver cells,48 
T cells in mice49 and rats,50 as well as murine basophils51 and 
monocytes52 and rat granulocytes and macrophages.50 The 
effect on various ILC subsets is poorly described. Thus, we 
cannot conclude that the effects we observed were solely the 
result of NK or even uNK cell reduction. Because the preg-
nant uterus contains relatively few immune cells with uNK 
cells representing the major population, we consider a relevant 
local effect mediated by other cells unlikely. Considering the 
heterogeneity of uNK cells in mouse and human, the effects 
of anti-asialo GM1 treatment reported herein may rely on the 
reduction of one of the subsets. One study found that anti-
asialo GM1 does not deplete tissue-resident NK cells in the 
kidney.53 But within that same article, the authors have shown 
that uterine tissue-resident NK cells seem to be an exception 
because they were uniformly expressing high levels of asialo 
GM1 that was similar to circulating NK cells in some strains.53 
Currently, the only way of temporarily depleting or reducing 
NK cells in the rat is administering antibodies or the antiserum 
anti-asialo GM1. Other groups have also successfully relied 
on this approach.16,46,54
We detected an increase in interleukin-15 gene expres-
sion in the mesometrial triangles of anti-asialo GM1-treated, 
preeclamptic rats at the end of pregnancy. In humans, inter-
leukin-15 is expressed by endometrial stromal cells55 and 
involved in recruitment of uNK cells to the endometrium.56 
One could interpret the increase in interleukin-15 in the meso-
metrial triangle after NK cell reduction as a homeostatic, com-
pensatory mechanism to replenish the uNK cell population, 
confirming the successful reduction of NK cells in the uterus.
The importance of uNK cells in the maintenance of preg-
nancy, particularly in late gestation, is still imperfectly under-
stood.57 Earlier animal investigations did not address disease 
processes such as hypertension in pregnancy or preeclampsia. 
We found vascular pathology in preeclamptic rats when NK 
cells are reduced, but we did not observe any effect on blood 
pressure and albuminuria. The data from our animal model do 
not support a major role for NK cells in this experimental pre-
eclampsia but definitely indicate an effect on uterine maternal 
vasculopathy and fetal growth.
Perspectives
An effect of natural killer cells on the preeclamptic phenotype 
could not be supported by our results. However, their reduc-
tion exerts a degenerative vascular effect on the maternal side 
of the uteroplacental unit that is associated with fetal growth 
restriction in wild-type rats. These complex results nonethe-
less direct a therapeutic focus on new targets. Viewing pre-
eclampsia as a NK cell disease in terms of modulation would 
be a shift from current thinking. Because no therapeutic 
options have developed for patients, this method of thought 
could direct future ideas.
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What Is New?
•	We report the first interventional study of reducing natural killer cells in 
an established rat model for preeclampsia.
•	Substantial reduction of natural killer cells is not altering the preeclamp-
tic phenotype.
•	We are the first to describe that reduction of natural killer cells induces 
maternal uterine vasculopathy in hypertensive rat pregnancy.
What Is Relevant?
•	 In preeclamptic rats, reduction of natural killer cells alters the uteropla-
cental unit with a decrease in interstitial trophoblast cell invasion and an 
induction of maternal vasculopathy with degenerative vessels exhibiting 
excessive fibrosis, but it did not modify maternal hypertension and albu-
minuria. In wild-type rats, reduction of natural killer cells also induces 
maternal uterine vasculopathy, which is associated with fetal growth 
restriction. The work directs attention to a different and novel aspect 
of immunology.
Summary
This study demonstrates a role for natural killer cells in trophoblast 
cell invasion and in maintenance of vascular integrity in the uterus 
needed for fetal growth.
Novelty and Significance
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1
Materials and Methods 
 
Animals and procedures 
 Local German authorities approved the studies that were conducted in accordance 
with the National Institutes of Health (NIH) guide for the care and use of laboratory animal 
standards. Our model involves two Sprague-Dawley rat lines: female rats expressing the 
human angiotensinogen (hAOGEN) and male rats expressing the human renin (hREN) gene. 
After mating, the dam develops severe hypertension1 and some target organ damage in the 
second half of pregnancy.2 At the end of pregnancy, the fetuses exhibit low birth weight and 
increased brain/liver weight ratio compared to normal non-transgenic Sprague-Dawley 
offspring confirming intrauterine growth restriction.3 The placentas in preeclamptic (PE) 
dams are lighter than those in control rats.4 Together with the group of Robert Pijnenborg, we 
had investigated the uteroplacental unit in this model and had shown a pathological 
endovascular trophoblast cell invasion with an altered uteroplacental vascular remodeling.5-7 
Ganglio-N-tetraosylceramide (asialo GM1) is a glycolipid expressed on natural killer cells 
(NK cells) in mice,8 rats,9 and humans.10 The antiserum anti-asialo GM1 successfully 
depletes NK cells in mice8 and rats.11 It also depletes uterine NK cells (uNK cells).11 We 
administered 0.5 ml rabbit anti-asialo GM1 antiserum (Wako Pure Chemical Industries) to 
pregnant dams intraperitoneally on day 5 and day 10 of pregnancy according to a protocol 
published by other investigators earlier.11 Pregnancy day 1 was defined by the presence of a 
vaginal copulation plug. Control PE rats received 0.5 ml rabbit serum (Jackson 
ImmunoResearch Laboratories). Rats from each group were anesthetized and euthanized for 
analysis either on day 15 or day 21 of pregnancy. Preeclamptic pregnant rats observed until 
pregnancy day 21 received continuous blood pressure monitoring by radiotelemetry (Data 
Science International). In healthy wild type Sprague-Dawley rats (SD), blood pressure was 
obtained by tail cuff measurement on pregnancy days 5, 10, 15/16, and 20/21. For 
quantification of 24 hours albumin excretion, rats were placed in metabolic cages and urine 
was collected (on pregnancy day 18/19 in PE rats, and on pregnancy day 17/18 in SD rats). 
Urinary albumin excretion was analyzed by ELISA (CellTrend). Serum cystatin C was 
determined by ELISA (BioVendor) according to manufacturer´s protocol. Serum creatinine 
was assessed by an automated clinical method (HELIOS Klinikum Berlin-Buch). 
In our study, we examined two different rat strains, transgenic PE Sprague-Dawley rats and 
healthy wild type SD rats. Maternal blood pressure, albuminuria, fetal and uteroplacental 
weights and ratios, and analysis of uterine vasculopathy has been evaluated in PE mother rats 
(n=7 anti-asialo GM1-treated rats and n=5 normal rabbit serum-treated rats) and SD mother 
rats (n=6 or 7 anti-asialo GM1-treated rats and n=5 or 6 normal rabbit serum-treated rats) on 
pregnancy day 21. Proof of NK cell reduction has been performed in PE rats on pregnancy 
day 15 (flow cytometry spleen: n=3 anti-asialo GM1-treated rats and n=3 normal rabbit 
serum-treated rats; histology uterus: n=3 anti-asialo GM1-treated rats and n=3 normal rabbit 
serum-treated rats; gene expression uterus: n=2 anti-asialo GM1-treated rats and n=4 normal 
rabbit serum-treated rats). Histological evaluation of trophoblast cell invasion and spiral 
artery remodeling has been performed in PE rats on pregnancy day 21 (n=8 uteroplacental 
units out of 7 anti-asialo GM1-treated rats and n=5 uteroplacental units out of 5 normal rabbit 
serum-treated rats). Maternal angiogenic profil in plasma has been evaluated in PE rats on 
pregnancy day 21 (n=7 anti-asialo GM1-treated rats and n=5 normal rabbit serum-treated 
rats). Gene expression of interleukin 15 in the uteroplacental unit has been analyzed in PE 
rats on pregnancy day 21 (n=5 out of 7 anti-asialo GM1-treated rats and n=5 out of 5 normal 
rabbit serum-treated rats). Angiogenic profil of the uteroplacental unit has been analyzed in 
PE rats on pregnancy day 21. Maternal serum creatinine, cystatine C, and body weight has 
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been evaluated in PE rats on pregnancy day 21 (n=7 anti-asialo GM1-treated rats and n=4 or 
5 normal rabbit serum-treated)  
 
RNA isolation, reverse transcription polymerase chain reaction and protein isolation 
 We isolated total mRNA from mesometrial triangle and placentas (together called 
uteroplacental unit) using QIAzol Lysis Reagent, RNeasy Mini Kit, and RNase-Free DNase 
Set (all Qiagen) according to the manufacturer´s protocol. Then, RNA was transcribed into 
cDNA by the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) with a 
DNA Thermal Cycler (Perkin Elmer) and analyzed in triplicates by real time quantitative 
polymerase chain reaction on 7500 Fast Real-Time PCR System (Applied Biosystem). 
Results were normalized to 18s. We designed our primers and probes (BioTeZ Berlin Buch 
GmbH) with Primer Express 3.0 (Applied Biosystems). Sequences are listed in the 
Supplementary Table S1. Proteins were isolated by homogenization in 
radioimmunoprecipitation assay buffer (RIPA buffer) supplemented with proteinase 
inhibitors. The placental like growth factor (PlGF) protein concentration was measured with 
the mouse PlGF-2 Quantikine ELISA Kit (R&D Systems), the soluble fms-like tyrosine 
kinase 1 (sFLT-1) protein concentration with the rat sFLT-1 ELISA Kit (MyBioSource). 
 
Flow cytometry 
 Preeclamptic rats having received anti-asialo GM1 (n=3) or normal rabbit serum 
(n=3), respectively, on pregnancy days 5 and 10 were euthanized on pregnancy day 15. 
Spleen was removed and a single cell suspension established by mechanical disintegration. 
After incubation in erythrolysis buffer (NH4Cl, NaHCO3, EDTA) cells were labeled with 
fluoresceinisothiocyanate (FITC)-conjugated mouse anti-rat CD161 (mouse IgG1 κ, clone 
10/78, Biolegend, CA, USA) and allophycocyanin (APC)-conjugated mouse anti-rat CD3 
(clone 1F4, BD PharmingenTM). For isotype control, cells were stained with FITC-
conjugated mouse IgG1 κ (clone MOPC-21, BioLegend). Flow cytometry was performed 
with a BD FACSCantoTM II (BD Biosciences). Data were analyzed with Flow Jo (Tree Star 
Inc.). Quantification of NK cells was performed on the lymphocyte population. 
 
Tissue preparations 
 We worked according to a published protocol with minor modifications.6 After the 
rats were sacrificed, placentas and associated mesometrial triangles were removed and fixed 
for 48 hours at room temperature in a fixative according to Backstead,12 which is a zinc-based 
formaldehyde-free fixative consisting of Tris(hydroxymethyl)-aminomethan-buffered 
calcium acetate (0.05%), zinc acetate (0.5%), and zinc chloride (0.5%). After fixation, the 
uteroplacental units were transferred to 70% ethanol and embedded in paraffin according to 
standard procedures. Then several series of ten parallel sections were cut from each 
uteroplacental unit. The distance between two series was at least 100 μm. Every section was 3 
– 5 μm thick. For further analysis, we selected one set displaying the most central parts of the 
uteroplacental unit. Within this set, a Masson-Goldner trichrome staining was performed. 
Additionally, parallel sections were stained with Periodic Acid Schiff (PAS; for general 
morphological evaluation and detection of fibrinoid), α-actin (marker for vascular smooth 
muscle cells, VSMC), cytokeratin (marker for trophoblast cells), CD31 (marker for 
endothelial cells), and Anti-Natural Killer Cell Activation Structures (ANK61, marker for 
NK cells; abcam). 
 
Immunohistochemistry and quantitative analysis of trophoblast cells 
 We applied a protocol published earlier.6 We used non-conjugated goat anti-mouse 
immunglobulins (Acris Antibodies) at a final dilution 1:50 and mounted the stained sections 
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in Depex mounting medium (VWR international GmbH) or Aqua-Poly/Mount (Polysciences, 
Inc.), respectively.  
We worked with the program AxioVision 4.1 linked to our Zeiss microscope Axio Imager 
M2 fitted with a camera AxioCam HRc (all Zeiss). Overview images of the whole 
uteroplacental unit were developed by using the module ‘panorama’ (Zeiss). Areas of 
mesometrial triangle and interstitial trophoblast cell invasion into mesometrial triangle were 
measured on the overview picture of the most central part of the uteroplacental unit with the 
module ‘interactive measurements’ (Zeiss). The mesometrial triangle was defined as the 
uterine tissue between the two uterine muscle layers. Numbers of trophoblast cells invading 
into the mesometrial triangle were semiquantitatively evaluated by counting trophoblast cells 
in microscopic fields at 40 x magnification. We only evaluated microscopic fields containing 
exclusively mesometrial triangle tissue without large blood vessels and according to 
availability, four to six randomly assigned fields were evaluated per uteroplacental unit 
without differentation between interstitial and endovascular trophoblast cells. Counts of 42 
microscopic fields totalized from all anti-asialo GM1-treated uteroplacental units were 
compared to counts from 29 microscopic fields totalized from all control rabbit serum-treated 
uteroplacental units. Endovascular trophoblast cell invasion was evaluated by examining 
every endovascularly invaded spiral artery cross section within the mesometrial triangle. The 
extension of endovascular trophoblast cell invasion was evaluated by scoring the percentage 
of vessel lumen circumference infiltrated by trophoblast cells as indicated by cytokerating 
positivity (1 point: 0-25%; 2 points: 26-50%; 3 point: 51-75%; 4 points: 76-100%). In case of 
very low and/or very thin antigen positivity (for cytokeratin), we diminished the score by one. 
Scores of spiral artery cross sections from all anti-asialo GM1-treated uteroplacental units 
(n=271 from 8 uteroplacental units) were compared to scores from all control rabbit serum-
treated uteroplacental units (n=188 from 5 uteroplacental units). The same score and analysis 
were applied to investigate the amount of smooth muscle cell tissue within the vessel wall. 
We interpreted a lower score (representing loss of smooth muscle cells) as vascular 
remodeling of the spiral artery. 
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Supplementary Table S1: Primer sequences for quantitative real-time reverse transcription 
polymerase chain reaction       
-------------------------------------------------------------------------------------------------------------------------- 
Gene              Primer             Sequence 
-------------------------------------------------------------------------------------------------------------------------- 
           forward         5´ ACATCCAAGGAAGGCAGCAG 3´ 
rat 18s           reverse         5´ TTTTCGTCACTACCTCCCCG 3´                             
                       probe         5´ FAM-CGCGCAAATTACCCACTCCCGAC-TAMRA 3´ 
        
           forward         5´ TGTACTACCTGTGTTTCCTTCTCAACA 3´   
rat IL-15#        reverse         5´ CACTGACACAGCCCAAAATGA 3´                                   
                       probe         5´ FAM-CACTTCTTAACTGAGGCTGGCATCCATGTC-TAMRA 3´
     
                       forward         5´ CATCACAGGAGAGGTTGAGAACAC 3 
rat NCR1*      reverse            5´ GGTCAAACTCCCAATAATCAAGAGA 3´ 
                       probe         5´ FAM-AGCCTTGCACCCACAGACCCTGTTTC-TAMRA 3 
-------------------------------------------------------------------------------------------------------------------------- 
#  interleukin 15 
* NCR1: natural cytotoxicity receptor 1 
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 Supplementary Figure S1: Influence of anti-asialo GM1 on maternal uterine vessels in 
preeclamptic rats (PE) on pregnancy day 21 
Degenerative maternal vasculopathy in the mesometrial triangle of PE rats. Same vessels as 
in Figure 2, but here shown in 40 x magnification. Explanations please see legend to Figure 
2. 
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Supplementary Figure S2: Influence of anti-asialo GM1 on interstitial trophoblast cell 
invasion in preeclamptic rats (PE) on pregnancy day 21 
A: Anti-asialo GM1 decreased the area of interstitial trophoblast cell invasion into 
mesometrial triangle in PE rats (68 ± 3% in the anti-asialo GM1 PE group vs. 77 ± 3% in the 
control rabbit serum PE group; p=0.045, unpaired t-test, shown mean with SEM). The two 
pictures below show uteroplacental units consisting of placenta (=fetal part; below) and 
mesometrial triangle (=maternal part; above). It is a cytokeratin staining of trophoblast cells, 
which appear in black dark after nitro-blue tetrazolium chloride (NBT) and 5-bromo-4-
chloro-3'-indolyphosphate p-toluidine salt (BCIP) staining and counterstaining with Periodic 
Acid Schiff (PAS) and hematoxylin, 10 x magnification. 
B: The number of invading trophoblast cells in the mesometrial triangle was decreased in 
anti-asialo GM1-treated PE rats (221 cells per microscopic field in 40 x magnification vs. 275 
cells in the control rabbit serum PE group; p=0.0493, Mann Whitney test, shown median with 
interquartile range). Shown are two exemplary pictures of trophoblast cells in the 
mesometrial triangle. Cytokeratin staining of trophoblast cells, which appear in black after 
9
NBT and BCIP staining and counterstaining with PAS and hematoxylin, 40 x magnification. 
The lower number of trophoblast cells in anti-asialo GM1-treated PE animals is apparent. 
A+B: n=8 uteroplacental units out of 7 anti-asialo GM1-treated PE rats and n=5 
uteroplacental units out of 5 control rabbit serum-treated PE rats. In B, n=42 microscopic 
fields were counted in total in the anti-asialo GM1 PE group and n=29 in total in the control 
rabbit serum PE group. 
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Supplementary Figure S3: Influence of anti-asialo GM1 on endovascular trophoblast 
cell invasion in preeclamptic rats (PE) on pregnancy day 21 
A: Anti-asialo GM1 did not change the mean number of infiltrated spiral artery cross sections 
per mesometrial triangle in PE rats (33.9 ± 4.0 vs. 37.6 ± 9.3 in the control rabbit serum PE 
group; p=0.7, unpaired t-test, shown mean with SEM). 
B: The ratio of infiltrated spiral artery cross sections on all spiral artery cross sections within 
the mesometrial triangle was also not different in PE rats after anti-asialo GM1 application 
(46 ± 3% vs. 52 ± 9% in the control rabbit serum PE group; p=0.6, unpaired t-test with 
Welch´s correction, shown mean with SEM). 
C: Anti-asialo GM1 did not change the extent of endovascular trophoblast cell invasion 
within the circumference of the spiral artery lumen in PE rats (percentage of vessel lumen; 
score of 2.0 in n=271 vs. 2.0 in n=188 in the control rabbit serum PE group; p=0.4, Mann 
Whitney test, shown median with interquartile range).  
D: The presence of muscle tissue (α-actin) in the wall of trophoblast-invaded spiral artery 
cross sections was not changed in PE rats after anti-asialo GM1 therapy (score of 3.0 in 
n=271 vs. 3.0 in n=188 in the control rabbit serum PE group; p=0.2, Mann Whitney test, 
shown median with interquartile range).  
E: Example of an endovascularly invaded spiral artery cross section in a PE rat: On the left, 
there is a Periodic Acid Schiff staining (PAS) and counterstaining with hematoxylin. It stains 
fibrinoid red, an extracellular matrix typically secreted by endovascular trophoblast cells. 
Next to it, there is a cytokeratin staining of trophoblast cells, which appear in black after 
nitro-blue tetrazolium chloride (NBT) and 5-bromo-4-chloro-3'-indolyphosphate p-toluidine 
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salt (BCIP) staining and counterstaining with PAS and hematoxylin. The third picture is an α-
actin staining of smooth muscle cells, which appear in brown after diaminobenzidine staining 
and counterstaining with PAS and hematoxylin. On the right, there is a CD31 staining of 
endothelial cells (again NBT and BCIP staining and counterstaining with PAS and 
hematoxylin). The arrows highlight the right area of the spiral artery cross section, which is 
endovascularly invaded by trophoblast cells. In the same area, there is an absence of smooth 
muscle cells and an accumulation of fibrinoid, which is all together interpreted as remodeling 
of the artery in this area; all pictures 10 x magnification. 
A-D: n=8 uteroplacental units out of 7 anti-asialo GM1-treated PE rats and n=5 
uteroplacental units out of 5 control rabbit serum-treated PE rats. In C+D, n=271 spiral artery 
cross sections were counted in total in the anti-asialo GM1 PE group and n=188 in total in the 
control rabbit serum PE group. 
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Supplementary Figure S4: Influence of anti-asialo GM1 on angiogenic profile and 
interleukin 15 in preeclamptic rats (PE) on pregnancy day 21 
A: The soluble fms-like tyrosine kinase 1 (sFLT-1) protein concentration in PE placenta was 
decreased after anti-asialo GM1 (0.2 ± 0.03 ng/mg total protein vs. 0.3 ± 0.03 ng/mg total 
protein in the control rabbit serum PE group; p=0.03, unpaired t-test, shown mean with 
SEM); n=8 out of 7 anti-asialo GM1-treated PE rats and n=7 out of 5 control rabbit serum-
treated PE rats, measured by ELISA. The sFLT-1 protein concentration was not different in 
PE mesometrial triangle (0.5 ng/mg total protein vs. 0.4 ng/mg total protein in the control 
rabbit serum PE group; p=0.8, Mann Whitney test, shown median with interquartile range); 
n=3 out of 3 anti-asialo GM1-treated PE rats and n=5 out of 4 control rabbit serum-treated PE 
rats, measured by ELISA. 
B: The placental like growth factor (PlGF) protein concentration in PE placenta was 
decreased after anti-asialo GM1 (0.2 ± 0.03 ng/mg total protein vs. 0.5 ± 0.06 ng/mg total 
protein in the control rabbit serum PE group; p=0.004, unpaired t-test, shown mean with 
SEM); n=7 out of 6 anti-asialo GM1-treated PE rats and n=7 out of 5 control rabbit serum-
treated PE rats, measured by ELISA. The PlGF protein concentration was not different in PE 
mesometrial triangle (0.8 ng/mg total protein vs. 1.2 ng/mg total protein in the control rabbit 
serum PE group; p=1.0, Mann Whitney test, shown median with interquartile range); n=3 out 
of 3 anti-asialo GM1-treated PE rats and n=5 out of 4 control rabbit serum-treated PE rats, 
measured by ELISA. 
C: There was no difference in the sFLT-1/PLGF ratio in PE placenta (0.8 ± 0.1 vs. 0.7 ± 0.1 
in the control rabbit serum PE rats; p=0.6, unpaired t-test, shown mean with SEM; n=7 out of 
6 anti-asialo GM1-treated PE rats and n=7 out of 5 control rabbit serum-treated PE rats) or 
PE mesometrial triangle (0.6 vs. 0.4 in the control rabbit serum PE rats; p=0.6, Mann 
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Whitney test, shown median with interquartile range; n=3 out of 3 anti-asialo GM1-treated 
PE rats and n=5 out of 4 control rabbit serum-treated PE rats) after anti-asialo GM1 treatment 
(single values from Supplementary Figures S4A + B). 
D: There was no difference in the sFLT-1/PLGF ratio in maternal plasma after anti-asialo 
GM1 application in PE rats (7.9 ± 1.2 vs. 8.8 ± 1.5 in the control rabbit serum PE group; 
p=0.6, unpaired t-test, shown mean with SEM); measured by ELISA; n=7 rats in the anti-
asialo GM1 PE group and n=5 in the control rabbit serum PE group.  
E: In the placenta of anti-asialo GM1-treated PE rats, there was a downregulation of 
interleukin 15 (IL-15) gene expression by 14% (p=0.03, unpaired t-test with Welch´s 
correction, shown mean with SEM). In mesometrial triangle, however, anti-asialo GM1 
application increased IL-15 expression by 47% (p=0.006, unpaired t-test, shown mean with 
SEM); n=5 per organ per group, measured by quantitative real-time reverse transcription 
polymerase chain reaction (qRT-PCR). 
14




 Supplementary Figure S5: Influence of anti-asialo GM1 on fetal outcome and maternal 
signs in preeclamptic rats (PE) on pregnancy day 21 
A: Fetal liver weight was decreased after treatment with anti-asialo GM1 in PE rats (163.3 
mg vs. 183.8 mg in the control rabbit serum PE group; p=0.03, Mann Whitney test, shown 
median with interquartile range); n=73 fetuses out of n=7 anti-asialo GM1-treated PE mother 
rats and n=55 fetuses out of n=5 normal rabbit serum-treated PE mother rats. 
B: There was no difference in fetal brain weight between both PE groups after anti-asialo 
GM1 therapy (149.2 mg vs. 145.6 mg in the control rabbit serum PE group; p=0.9, Mann 
Whitney test, shown median with interquartile range); n=72 fetuses out of n=7 anti-asialo 
GM1-treated PE mother rats and n=55 fetuses out of n=5 normal rabbit serum-treated PE 
mother rats. 
C: Treatment with anti-asialo GM1 did not change mean number of fetuses per PE rat (10.7 ± 
1.3 vs. 11.2 ± 1.3 in the control rabbit serum PE group; p=0.8, unpaired t-test, shown mean 
with SEM); n=7 mother rats in the anti-asialo GM1 PE group and n=5 mother rats in the 
control rabbit serum PE group. 
D: Number of resorptions per PE rat was not different between the two groups (1.0 vs. 1.0 in 
the control rabbit serum group; p=0.6, Mann Whitney test, shown median with interquartile 
range); n=7 mother rats in the anti-asialo GM1 PE group and n=5 mother rats in the control 
rabbit serum PE group. 
E: Mean 24 hours albuminuria on pregnancy day 18 and 19 was not different after anti-asialo 
GM1 treatment in PE rats (16.5 ± 3.7 mg vs. 7.0 ± 2.3 mg in the control rabbit serum PE 
group; p=0.1, unpaired t-test, shown mean with SEM); n=7 PE mother rats in the anti-asialo 
GM1 group and n=5 PE mother rats in the control rabbit serum group; 
F: Serum creatinine after anti-asialo GM1 treatment displayed no difference between both PE 
groups (25.6 ± 1.4 µmol/l vs. 23.2 ± 1.7 µmol/l in the control rabbit serum PE group; p=0.3, 
unpaired t-test, shown mean with SEM); n=7 PE mother rats in the anti-asialo GM1 group 
and n=5 PE mother rats in the control rabbit serum group. 
G: Anti-asialo GM1 application did not change serum cystatin C in PE rats (865.9 ng/ml vs. 
789.8 ng/ml in the control rabbit serum PE group; p=0.7, Mann Whitney test, shown median 
with interquartile range); n=7 PE mother rats in the anti-asialo GM1 group and n=4 PE 
mother rats in the control rabbit serum group. 
H: Mean maternal body weight at the end of pregnancy was not different after anti-asialo 
GM1 treatment in PE rats (262 ± 4 g vs. 249 ± 13 g in the control rabbit serum PE group; 
p=0.4, unpaired t-test with Welch´s correction, shown mean with SEM); n=7 PE mother rats 
in the anti-asialo GM1 group and n=5 PE mother rats in the control rabbit serum group. 
16




Supplementary Figure S6: Influence of anti-asialo GM1 in wild type Sprague-Dawley 
rats (SD) on pregnancy day 21 
A: Anti-asialo GM1 decreased fetal liver weight in SD rats (299.8 ± 6.0 mg vs. 318.7 ± 7.5 
mg in the control rabbit serum SD group; p=0.0498, unpaired t-test, shown mean with SEM). 
B: Fetal brain weight was decreased after treatment with anti-asialo GM1 in SD rats (153.3 ± 
2.4 mg vs. 167.1 ± 3.1 mg in the control rabbit serum SD group; p=0.0007, unpaired t-test, 
shown mean with SEM). 
A+B: n=50 fetuses out of n=6 anti-asialo GM1-treated SD mother rats and n=46 fetuses out 
of n=6 normal rabbit serum-treated SD mother rats. 
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